| Issuer | % of Class | Filed |
|---|---|---|
|
Tyra Biosciences, Inc.
13G/A
Amendment 1
TYRA · 90240B106
|
4.8% |
5/14/2026
Event 3/31/2026
|
|
Tyra Biosciences, Inc.
13G
TYRA · 90240B106
|
5.1% |
2/13/2026
Event 12/31/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.